A. M. Blee

XPA tumor variants lead to defects in NER that sensitize cells to cisplatin

This study identifies XPA tumor variants that impair NER, increasing cisplatin sensitivity, and provides mechanistic insights for variant effect prediction.

An active learning framework improves tumor variant interpretation

This study applies active learning to improve variant interpretation for tumor genomes, showing better performance than traditional methods in predicting variant effects on cancer treatment.